<qa>  What is the age of the patient that increases treatment related mortality?2. Conditions that increase treatment related mortality: need one or more to be eligible: Age 50 years; EF of less than 45; DLCO less than 50 or FEVI 50-75 of predicted value; Diabetes Mellitus; Renal Insufficiency but creatinine clearance not less than 25 mLmin; Prior recent history of systemic fungal infection; 3rd or greater remission of AML or ALL; Significant Grade III or IV neurologic or hepatic toxicity from previous treatment; More than 1 year from diagnosis CML or Myeloma patients ONLY; Multiple types of treatment regimens equal to or more than 3; Significant Grade III or IV neurologic or hepatic toxicity from previous treatment; Prior autologous or allogeneic stem cell transplantation. 